Overactive bladder OAB is a common condition, especially in middle aged women, requiring long term therapy with anticholinergics to maintain symptoms relief. The aim of the study was to determine the effect of tolterodine extended release ER used for OAB treatment on the sexual function of women. Between August and August , women with confirmed OAB, attended Urogynecology Outpatient Clinic and were prospectively enrolled in this study. A statistically significant increase was noted in group B in domains of desire pre-treatment 2. This preliminary study demonstrates that treatment of OAB with tolterodine ER was found to have positive effect on sexual function of patients with OAB. Overactive bladder OAB is a symptom-driven condition characterized by urinary urgency with or without urge incontinence and is usually associated with increased daytime frequency and nocturia 1.
oxybutynin extended release: Topics by reddirtprimitives.com
An extended-release formulation of oxybutynin chloride for the treatment of overactive urinary bladder. Detrusor instability, or urinary incontinence, is common in elderly patients, particularly elderly women. The clinical symptoms of overactive, or unstable, urinary bladder include urge urinary incontinence, urgency, and frequency. Mixed urinary incontinence, which comprises urge urinary incontinence and stress incontinence, is manifested by increased intraabdominal pressure on coughing or sneezing.
In the two studies, participants with overactive bladder were treated with extended-release oxybutynin Ditropan XL] and were evaluated for the effect of the drug on their sexual functioning and activities. Study I was a week, open-label study of women with urge incontinence and other overactive bladder symptoms. The women received an individual titrated dose of 5 to 30 mg oxybutynin and completed daily urinary diaries and the question Urge Incontinence Impact Questionnaire U-IIQ with sexual function domain at baseline and post treatment. Study II, had a similar design to study I and was 12 months in duration. The subjects completed the question Individual Incontinence Impact Questionnaire, including a sexual function domain at baseline and after three months of treatment.
Peeing during sex is a very common concern. As many as 60 percent of women who have some level of general incontinence experience leakage during sex. Instead they may be experiencing female ejaculation during orgasm. Regarding female ejaculation, what the fluid actually does has been debated.